drugset / Trial / NCT05125042

Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation

NCT05125042

Unknown 120 enrolled Shanghai Chest Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a multi-center, 2-arm, assessor and statistician blinded, pilot randomized controlled trial, to evaluate the effect of catgut embedding in acupoints of Neiguan and Zusanli in reducing early recurrence and improving long-term prognosis in patients with persistent AF after CA..

Timeline

Start
2021-12-01
Primary completion
2023-06-30
Completion
2023-12-20

Drugs

EvaluationDrugModalityDoseRoute
Background Amiodarone Small molecule 200 mg